Download PDF
CC BY-NC-ND 4.0 · Journal of Coloproctology 2022; 42(04): 315-321
DOI: 10.1055/s-0042-1756681
Original Article

Pattern of Rectal Cancer Recurrence Following Potentially Curative Surgical Treatment

Gustavo Sevá-Pereira 
1   Coloproctology Group, Hospital Municipal Dr. Mario Gatti, Campinas, SP, Brazil
,
Vitória de Souza Oliveira
1   Coloproctology Group, Hospital Municipal Dr. Mario Gatti, Campinas, SP, Brazil
,
Gabriela Domingues Andrade Ribeiro
1   Coloproctology Group, Hospital Municipal Dr. Mario Gatti, Campinas, SP, Brazil
,
Paula Buozzi Tarabay
1   Coloproctology Group, Hospital Municipal Dr. Mario Gatti, Campinas, SP, Brazil
,
Marcello Imbrizzi Rabello
1   Coloproctology Group, Hospital Municipal Dr. Mario Gatti, Campinas, SP, Brazil
,
Joaquim José de Oliveira-Filho
1   Coloproctology Group, Hospital Municipal Dr. Mario Gatti, Campinas, SP, Brazil
› Author Affiliations Funding Declaration No funding was received for the research submitted to the journal.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Survival in rectal cancer has been related mainly to clinical and pathological staging. Recurrence is the most challenging issue when surgical treatment of rectal cancer is concerned. This study aims to establish a recurrence pattern for rectal adenocarcinoma submitted to surgical treatment between June 2003 and July 2021. After applying the exclusion criteria to 305 patients, 166 patients were analyzed. Global recurrence was found in 18.7% of them, while 7.8% have had local recurrence. Recurrences were diagnosed from 5 to 92 months after the surgical procedure, with a median of 32.5 months. Follow-up varied from 6 to 115 months. Recurrence, in literature, is usually between 3 and 35% in 5 years and shows a 5-year survival rate of only 5%. In around 50% of cases, recurrence is local, confined to the pelvis. This study was consonant with the literature in most aspects evaluated, although a high rate of local recurrence remains a challenge in seeking better surgical outcomes.

Keywords

rectal neoplasm - recurrence - neoplasm recurrence - colorectal surgery

Author's Contribution

Gustavo Sevá-Pereira and Vitória Souza Oliveira were responsible for conception and design and wrote the main manuscript text.


Paula Buozzi Tarabay and Gabriela Domingues Andrade Ribeiro reviewed the data analisys.


Joaquim José de Oliveira Filho helped with data collection and critically reviewed the manuscript.


Marcello Imbrizzi Rabello helped with the writing correction and critically reviewed the manuscript.


Data Availability Statement

The data that support the findings of this study are available on reasonable request from the corresponding author, G. S. P. The data are not publicly available due to ethical and privacy restrictions.




Publication History

Received: 22 June 2022

Accepted: 18 August 2022

Article published online:
10 October 2022

© 2022. Sociedade Brasileira de Coloproctologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 INCA – Instituto Nacional do Câncer – Estimativa. INCA – Instituto Nacional do Câncer - Estimativa 2020. In: https://www.inca.gov.br/estimativa/sintese-de-resultados-e-comentarios (acessado em 03.01.2021)
  • 2 Komen N, Dewint P, Van den Broeck S, Pauli S, de Schepper H. Rectal cancer surgery : what's in a name?. Acta Gastroenterol Belg 2019; 82 (01) 67-74
    PubMedSearch in Google Scholar
  • 3 Wong MCS, Huang J, Lok V. et al. Differences in Incidence and Mortality Trends of Colorectal Cancer Worldwide Based on Sex, Age, and Anatomic Location. Clin Gastroenterol Hepatol 2021; 19 (05) 955-966.e61
    CrossrefPubMedSearch in Google Scholar
  • 4 Priolli DG, Cardinalli IA, Pereira JA, Alfredo CH, Margarido NF, Martinez CA. Metastatic lymph node ratio as an independent prognostic variable in colorectal cancer: study of 113 patients. Tech Coloproctol 2009; 13 (02) 113-121
    CrossrefPubMedSearch in Google Scholar
  • 5 Habr-Gama A, São Julião GP, Gama-Rodrigues J. et al. Baseline T Classification Predicts Early Tumor Regrowth After Nonoperative Management in Distal Rectal Cancer After Extended Neoadjuvant Chemoradiation and Initial Complete Clinical Response. Dis Colon Rectum 2017; 60 (06) 586-594
    CrossrefPubMedSearch in Google Scholar
  • 6 You YN, Hardiman KM, Bafford A. et al; On Behalf of the Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer. Dis Colon Rectum 2020; 63 (09) 1191-1222
    CrossrefPubMedSearch in Google Scholar
  • 7 Keller DS, Berho M, Perez RO, Wexner SD, Chand M. The multidisciplinary management of rectal cancer. Nat Rev Gastroenterol Hepatol 2020; 17 (07) 414-429
    CrossrefPubMedSearch in Google Scholar
  • 8 Räsänen M, Carpelan-Holmström M, Mustonen H, Renkonen-Sinisalo L, Lepistö A. Pattern of rectal cancer recurrence after curative surgery. Int J Colorectal Dis 2015; 30 (06) 775-785
    CrossrefPubMedSearch in Google Scholar
  • 9 Sevá-Pereira G, Cypestre RN, Filho JO, Moraes SP, Tarabay PB. Recurrence of rectal cancer after surgical treatment. Analysis of 122 patients in tertiary care center. J Coloproctol 2018; 38(01)
  • 10 Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17 (06) 1471-1474
    Search in Google Scholar
  • 11 Farhat W, Azzaza M, Mizouni A. et al. Factors predicting recurrence after curative resection for rectal cancer: a 16-year study. World J Surg Oncol 2019; 17 (01) 173
    CrossrefPubMedSearch in Google Scholar
  • 12 Glynne-Jones R, Wyrwicz L, Tiret E. et al; ESMO Guidelines Committee. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017; 28 (Suppl. 04) iv22-iv40 Erratum in: Ann Oncol. 2018 Oct 1;29(Suppl 4):iv263
    Search in Google Scholar
  • 13 van Oostendorp SE, Smits LJH, Vroom Y. et al. Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment. Br J Surg 2020; 107 (13) 1719-1730
    CrossrefPubMedSearch in Google Scholar
  • 14 Bridges LC, Honaker MD, Smith BE, Montgomery A. Insurance Status in Rectal Cancer is Associated With Age at Diagnosis and May be Associated With Overall Survival. Am Surg 2021; 87 (01) 105-108
    CrossrefPubMedSearch in Google Scholar
  • 15 Stoffel EM, Murphy CC. Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults. Gastroenterology 2020; 158 (02) 341-353
    CrossrefPubMedSearch in Google Scholar
  • 16 Dietz DW. Consortium for Optimizing Surgical Treatment of Rectal Cancer (OSTRiCh). Multidisciplinary management of rectal cancer: the OSTRICH. J Gastrointest Surg 2013; 17 (10) 1863-1868
    CrossrefPubMedSearch in Google Scholar
  • 17 Garcia-Aguilar J, Glynne-Jones R, Schrag D. Multimodal Rectal Cancer Treatment: In Some Cases, Less May Be More. Am Soc Clin Oncol Educ Book 2016; 35: 92-102
    CrossrefPubMedSearch in Google Scholar
  • 18 López-Campos F, Martín-Martín M, Fornell-Pérez R. et al. Watch and wait approach in rectal cancer: Current controversies and future directions. World J Gastroenterol 2020; 26 (29) 4218-4239
    CrossrefPubMedSearch in Google Scholar
  • 19 Hawkins AT, Albutt K, Wise PE. et al; Continuing Education Committee of the SSAT. Abdominoperineal Resection for Rectal Cancer in the Twenty-First Century: Indications, Techniques, and Outcomes. J Gastrointest Surg 2018; 22 (08) 1477-1487
    CrossrefPubMedSearch in Google Scholar
  • 20 Leal RF, Aryzono MLS, Fagundes JJ. et al. Recidiva pélvica de adenocarcinoma de reto - abordagem cirúrgica. Rev Bras Coloproctol 2008; 28: 40-45
    CrossrefSearch in Google Scholar
  • 21 Palmer G, Martling A, Cedermark B, Holm T. A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol 2007; 14 (02) 447-454
    CrossrefPubMedSearch in Google Scholar
  • 22 Guraya SY. Pattern, Stage, and Time of Recurrent Colorectal Cancer After Curative Surgery. Clin Colorectal Cancer 2019; 18 (02) e223-e228
    CrossrefPubMedSearch in Google Scholar
  • 23 Mussnich HG, Moreira LF, Gus P, Pimentel M, Simon T, Santos MB. Prognostic Factors and survival in primary rectal adenocarcinoma. Rev Bras Coloproctol 2008; 28: 62-71
    Search in Google Scholar
  • 24 Cai Y, Li Z, Gu X, Fang Y, Xiang J, Chen Z. Prognostic factors associated with locally recurrent rectal cancer following primary surgery (Review). (Review) Oncol Lett 2014; 7 (01) 10-16
    CrossrefPubMedSearch in Google Scholar
  • 25 Mahadevan LS, Zhong J, Venkatesulu B. et al. Imaging predictors of treatment outcomes in rectal cancer: An overview. Crit Rev Oncol Hematol 2018; 129: 153-162 Erratum in: Crit Rev Oncol Hematol. 2019 Feb;134:71
    CrossrefPubMedSearch in Google Scholar
  • 26 Jankowski M, Las-Jankowska M, Rutkowski A. et al. Clinical Reality and Treatment for Local Recurrence of Rectal Cancer: A Single-Center Retrospective Study. Medicina (Kaunas) 2021; 57 (03) 286
    CrossrefPubMedSearch in Google Scholar